Custom Data
Data curated to answer novel research questions
Flatiron offers tailored oncology real-world data and solutions to meet your specific evidence needs through custom real-world datasets, variables, and more precise patient cohorts.
Stages of custom data projects
01
Planning and scoping
At Flatiron, we work with our biopharma partners to align on scope, cohort, novel variables and project timelines. We can help evaluate study design and data fitness for use.
02
Execution
We oversee data abstraction while ensuring patient-level and cohort-level quality assurance processes. We also help to build novel data models and test their feasibility.
03
Delivery
Deliverables include a data dictionary, analytic guides and the data file, with options for analytic and regulatory services and deliverables.
04
Post-delivery
We provide training and analytic guidance and can provide support to you with analytic and publication services.
Pioneering real-world evidence generation
5+
years experience delivering custom real-world datasets
50+
novel derived variables created
350+
customized projects for life sciences customers
Flatiron offers novel variables that drive groundbreaking research
Outcome variables
Real-world response, real-world progression, mortality, and adverse events with additional variables are available upon request.
Disease and patient characteristics
Comorbidities, brain metastases, and additional malignancies.
Drug treatment variables
Dosing details and reasons for discontinuation of oral therapies.
Procedures and tests
Treatment for brain/CNS metastases and radiation/surgery data.
hear from our customers
“These Flatiron analyses, along with other real-world analyses that we had conducted, strengthened our U.S. regulatory filing, which ultimately led to [the therapy] being approved in June 2020.”
Pranav Abraham, PhD
Director, Global Health Economics, Rare Hematology, Bristol Myers Squibb
Source: ResearchX